Allan RyanSep 182 minStudies examine optimal topical, systemic Txs for ADTwo reviews from researchers at McMaster University in Hamilton have identified the most effective topical and systemic treatments for...
John EvansSep 12 minDupilumab improves blood vessel barrier function in ADIn a recent study, researchers at National Jewish Health investigated the impact of dupilumab on the vascular barrier function in...
Allan RyanSep 26, 20222 minDupilumab effective in relieving AD symptoms in children aged six months to six yearsChildren with eczema between the ages of six months and six years benefit from treatment with dupilumab, according to the results of a...